A Fatal Case of Severe Hemolytic Disease of Newborn Associated with Anti-Jk(b).
10.3346/jkms.2006.21.1.151
- Author:
Won Duck KIM
1
;
Young Hwan LEE
Author Information
1. Department of Pediatrics, Dongguk University, College of Medicine, Gyeongju, Korea.
- Publication Type:Case Report
- Keywords:
Anemia, Hemolytic, Autoimmune;
Erythrobastosis, Fetal;
Infant, Newborn;
Anti-Jk(b)
- MeSH:
Bilirubin/blood;
Erythroblastosis, Fetal/*blood;
Fatal Outcome;
Female;
Humans;
Infant, Newborn;
Isoantibodies/blood;
Kidd Blood-Group System/*immunology
- From:Journal of Korean Medical Science
2006;21(1):151-154
- CountryRepublic of Korea
- Language:English
-
Abstract:
The Kidd blood group is clinically significant since the Jk antibodies can cause acute and delayed transfusion reactions as well as hemolytic disease of newborn (HDN). In general, HDN due to anti-Jk(b) incompatibility is rare and it usually displays mild clinical symptoms with a favorable prognosis. Yet, we apparently experienced the second case of HDN due to anti-Jk(b) with severe clinical symptoms and a fatal outcome. A female patient having the AB, Rh(D)-positive boodtype was admitted for jaundice on the fourth day after birth. At the time of admission, the patient was lethargic and exhibited high pitched crying. The laboratory data indicated a hemoglobin value of 11.4 mg/dL, a reticulocyte count of 14.9% and a total bilirubin of 46.1 mg/dL, a direct bilirubin of 1.1 mg/dL and a strong positive result (+++) on the direct Coomb's test. As a result of the identification of irregular antibody from the maternal serum, anti-Jk(b) was detected, which was also found in the eluate made from infant's blood. Despite the aggressive treatment with exchange transfusion and intensive phototherapy, the patient died of intractable seizure and acute renal failure on the fourth day of admission. Therefore, pediatricians should be aware of the clinical courses of hemolytic jaundice due to anti-Jk(b), and they should be ready to treat this disease with active therapeutic interventions.
